Category Archives: Pharmacogenomics

Dublin, Nov. 19, 2020 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis, and Executive and Consultant Guides 2021-2025" report has been added to ResearchAndMarkets.com's offering.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help understand test pricing in detail.

Forecast demand for new testing regimes or technologies. Make research investment decisions. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.

Cancer Gene Panels and Genomic Profiling are quickly changing the diagnosis and treatment of cancers. The market is moving out of a specialized niche and going mainstream as Oncologists begin routinely using information on the hundreds of genes related to cancer. The market is exploding as physicians use all the information they can get in the battle against cancer. And there is a lot of information to be had. But the COVID-19 Pandemic has impacted the market.

Comprehensive panels, genomic profiling, high-risk breast cancer panels. Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are already taking the lead. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of sequencing continues to fall.

The report includes detailed breakouts for 18 Countries and 4 Regions.

Key Topics Covered:

Cancer Panel Market - Strategic Situation Analysis & COVID Update

1. Introduction and Market Definition 1.1 What are Cancer Gene Panels and Profiling? 1.2 The Sequencing Revolution 1.3 Market Definition 1.4 Methodology 1.5 A Spending Perspective on Clinical Laboratory Testing 1.5.1 An Historical Look at Clinical Testing

2. Market Overview 2.1 Players in a Dynamic Market 2.1.1 Academic Research Lab 2.1.2 Diagnostic Test Developer2.1.3 Instrumentation Supplier 2.1.4 Distributor and Reagent Supplier 2.1.5 Independent Testing Lab2.1.6 Public National/regional lab 2.1.7 Hospital lab 2.1.8 Physician Office Labs 2.1.9 Audit Body 2.1.10 Certification Body2.2 Oncogenomics2.2.1 Carcinogenesis2.2.2 Chromosomes, Genes and Epigenetics 2.2.2.1 Chromosomes 2.2.2.2 Genes 2.2.2.3 Epigenetics 2.2.3 Cancer Genes 2.2.4 Germline vs Somatic 2.2.5 Gene Panels, Single Gene Assays and Multiplexing 2.2.6 Genomic Profiling 2.2.7 The Comprehensive Assay 2.2.8 Changing Clinical Role 2.2.9 The Cancer Screening Market Opportunity2.3 Cancer Management vs. Diagnosis 2.3.1 The Role of Risk Assessment 2.3.2 Diagnosis 2.3.3 Managing 2.3.4 Monitoring 2.4 Phases of Adoption - Looking into The Future 2.5 Structure of Industry Plays a Part 2.5.1 Hospital Testing Share 2.5.2 Economies of Scale2.5.2.1 Hospital vs. Central Lab 2.5.3 Physician Office Lab's 2.5.4 Physician's and POCT

3. Market Trends3.1 Factors Driving Growth3.1.1 Level of Care 3.1.2 Companion Dx 3.1.3 Immuno-oncology 3.1.4 Liability3.1.5 Aging Population3.2 Factors Limiting Growth3.2.1 State of knowledge3.2.2 Genetic Blizzard. 3.2.3 Protocol Resistance3.2.4 Regulation and coverage 3.3 Instrumentation and Automation 3.3.1 Instruments Key to Market Share 3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development3.4.1 Next Generation Sequencing Fuels a Revolution 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay

4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section

5. Profiles of Key Players

6. The Global Market for Cancer Gene Panels and Profiles

7. Global Cancer Gene Panels & Profiles Markets - By Type of Cancer 7.1 Comprehensive Panels & Profiles 7.2 Breast Cancer Gene Testing 7.3 Colorectal Cancer Gene Testing7.4 Gynecological Cancer Gene Testing 7.5 Blood Cancer Gene Testing 7.6 Prostate Cancer Gene Testing 7.7 Lung Cancer Gene Testing7.8 Other Cancer Gene Testing

8. Global Cancer Gene Testing Markets - Germline and Somatic 8.1 Global Market Somatic 7.3 Global Market Germline

9. Potential Market Opportunity Sizes 9.1 Potential Cancer Screening by Country: Lung, Breast & Colorectal 9.2 Potential Cancer Screening by Country: Prostate, Other Cancer & All Cancer 9.3 Potential Market Size - Cancer Diagnosis 9.4 Potential Market Size - Therapy Selection

Appendices

For more information about this report visit https://www.researchandmarkets.com/r/5bx3ai

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

More:
Global Genomic Cancer Panel and Profiling Markets Report 2021-2025: The Market is Moving Out of a Specialized Niche and Going Mainstream -...

New York, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Direct-to-Consumer Genetic Testing: Global Markets and Technologies" - https://www.reportlinker.com/p05987656/?utm_source=GNW

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR) and genotyping microarrays.

The report then discusses several of the significant large-scale population sequencing initiatives that are contributing to DTC genetic testing development. Key forces driving the market are enumerated.

The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2019 through September 2020. Industry subsectors analyzed include ancestry, clinical health, recreational health, sequencing data-based blockchain, sequencing instrument, long-read sequencing, sequencing informatics and PCR.

The market for DTC genetic testing is analyzed in depth. The market is analyzed by test purpose (ancestry, health, lifestyle); by technology platform (PCR, genotyping arrays, sequencing); by delivery format (test kits, virtual tests); and by geography (North America, Europe, Asia/Pacific, RoW).

The ancestry market segment is analyzed by technology and by ethnicity (African, Asian, European, Latino, other). The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and other). The lifestyle market segment is analyzed by technology and by application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness, other)

Market data covers 2019, 2020 (estimated) and 2025 (forecasted).

More than 55 companies in the DTC genetic testing industry are profiled in this report.

The analyst provides a summary of the main industry acquisitions and strategic alliances from January 2019 through September 2020, including key alliance trends.

Report Inludes: - 12 data tables and 39 additional tables - An overview of the global markets and technologies for direct to consumer (DTC) genetic testing - Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025 - Information on key genomic regions associated with genetic testing and description of instruments and technologies used for DTC genetic testing - Coverage of DNA sequencing; microarray; and software industries and description of the key initiatives in the genetic testing industry - Detailed analysis of the current market trends, market forecast and discussion of technological, regulatory and competitive elements as well as economic trends affecting the future marketplace for direct to consumer (DTC) genetic testing and impact analysis of COVID-19 on the market - Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry - Profiles of the key companies in the DTC testing industry, including Chendu 23Mofang Biotechnology Co. Ltd (23Mofand), Genetic Technologies Ltd, Illumina Inc., Myriad Genetics Inc., Thermo Fisher Scientific Inc., and Quest Diagnostics Inc.

Summary: Direct-to-consumer (DTC) genetic testing involves the analysis and interpretation of a persons genome. A consumer can access DTC genetic testing from a commercial company or from a health care provider.

DTC genetic testing has evolved in the past 10 years. Initially it focused on personal applications outside traditional health care, such as exploring ancestry and has trended toward interfacing with clinical care in non-traditional ways, such as partnerships between DTC companies with health systems.

Analysis of a customers genome helps to know about their ancestry inference, disease risks and other personal traits. Based on this, the main applications include ancestry, health and lifestyle.

Several factors are driving growth in the DTC genetic testing industry, including a shifting emphasis on health-related applications, the rise of personalized genomics and increasing convenience of ordering goods and services from virtual at-home settings. This latter trend has been accelerated by the COVID- 19 pandemic.

There is rising public awareness of DNA and its impact on health and genetic disorders, ancestry and lifestyle. These trends are having a favorable impact on the at-home genetic testing market. This report provides an in-depth analysis of the DTC genetic testing industryRead the full report: https://www.reportlinker.com/p05987656/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

See the rest here:
Direct-to-Consumer Genetic Testing: Global Markets and Technologies - GlobeNewswire

The National Human Genome Research Institute definesgenomic medicine asan emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., fordiagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use. Genomic medicine is a type of precision medicine in which genomics, epigenomics and other related data is used to accurately aid in individual disease diagnosis. Genomic medicine has novel applications in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease.Genomic medicine paves way for personalized medicine into clinics and has immense potential to reach the physicians and patients. Genomic medicine has been used for advanced sequencing in cancer pharmacogenomics, rare disorder diagnosis and for tracking of outbreaks of infectious diseases.

Genomic Medicine Market: Drivers & Restraints

Backed by government investments in precision medicine initiatives such as a multimillion dollar investment by President Obama in January 2015 which aims to improve how to treat and prevent a disease by laying emphasis on its genetic makeup is expected to boost the market growth. Clinical validity and utility of genomic medicine tests is a major issue witnessed in the global market. Also, lack of awareness among healthcare professionals, sluggish adoption of genome medicine, fluctuating regulatory landscape are the factors which could hamper growth of the global genomic medicine market.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/11323

Genomic Medicine Market: Segmentation

The global genomic medicine market is classified on the basis of application type, end use and region.

Based on application, the global genomic medicine market is segmented into the following:

Based on end use, the global genomic medicine market is segmented into the following:

Genomic Medicine Market: Overview

Genomic medicine is gaining momentum with expanding applications ranging from risk assessment and diagnosis in healthy individuals to genome-based treatment for patients with complicated disorders. Oncology is a major application of genomics medicine during cancer screening process as diagnostics for genetic and genomic markers. Oncology segment is expected to account for a major share in the global genomic medicine market. Genomic medicine is increasingly being used not only for research purpose but also in clinical applications. In clinical applications, genomic medicine will potentially enhance patient care.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/11323

Genomic Medicine Market: Region wise Overview

Geographically, global Genomic Medicine market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA). Owing to the presence of large number of academic as well as research institutions in the U.S. which are working on genomic medicine to discover next-generation genomic medicines, North America region is projected to lead the global genomic market in terms of value during the forecast period. Also, the presence of several universities offering educational programs coupled with opportunities in scientific research of genomic medicine in the North America and Europe is expected to have positive impact on the regional markets. The genomic medicine concept still in its nascent stage is yet to receive an impetus from the emerging market which are anticipated to hold smaller shares in the global market.

Genomic Medicine Market: Key Players

The key research institutes in global genomic medicine market are BioMed Central Ltd., Cleveland Clinic, The University of Texas MD Anderson Cancer Center, The Manchester Centre for Genomic Medicine, Center for Genomic Medicine to name a few. The focus of the top players will be on the identification of effective drug candidates particularly in cancer treatment based on the molecular structure of tumors.

You Can Request for TOC[emailprotected]

https://www.persistencemarketresearch.com/toc/11323

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

View post:
The Genomic Medicine market to go the reverse transversal way in the next decade - The Think Curiouser

Latest Genotyping Assay Market report evaluates the impact of Covid-19 outbreak on the industry, involving potential opportunity and challenges, drivers and risks and market growth forecast based on different scenario. Global Genotyping Assay industry Market Report is a professional and in-depth research report on the worlds major regional market.

This Genotyping Assay Market report will help the business leaders to detail better field-tested strategies and settle on educated choices to improved benefit

Get Exclusive Free Sample of Report on Genotyping Assay market is available at https://inforgrowth.com/sample-request/6401398/genotyping-assay-market

Top Players Listed in the Genotyping Assay Market Report areIllumina, Thermo Fisher Scientific, Roche Diagnostics Limited, Qiagen N.V., Danaher Corporation, Agilent Technologies, Fluidigm Corporation, GE Healthcare, Genewiz, Integrated Dna Technologies, Perkinelmer, Bio-Rad Laboratories, Eurofins Scientific, Pacific Biosciences of Californi.

Genotyping Assaymarket report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market Segmentations: Global Genotyping Assay market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer.

Based on type, report split into PCR, Sequencing, Microarray, Electrophoresis, MALDI-TO.

Based on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnolog.

Download the Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/6401398/genotyping-assay-market

The report introduces Genotyping Assay basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis. Insightful predictions for the Genotyping Assay Market for the coming few years have also been included in the report.

In the end, Genotyping Assayreport provides details of competitive developments such as expansions, agreements, new product launches, and acquisitions in the market for forecasting, regional demand, and supply factor, investment, market dynamics including technical scenario, consumer behavior, and end-use industry trends and dynamics, capacity, spending were taken into consideration.

Important Key questions answered in Genotyping Assaymarket report:

Get Special Discount Up To 50%, https://inforgrowth.com/discount/6401398/genotyping-assay-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898Website: http://www.inforgrowth.com

Read the original post:
Covid-19 Impact on Global Genotyping Assay Market (2020-2026) | Potential growth, attractive valuation make it is a long-term investment | Top...

Global Pharmacogenomics Market Report helps the readers to maximize their profits and business making ventures by gaining complete insights of Pharmacogenomics Industry. The latest developments and growth opportunities in Pharmacogenomics market are covered. Development trends, revenue analysis, Pharmacogenomics market share and market dynamics are presented to optimize the business. The vital Pharmacogenomics insights, opportunities in existing and emerging segments are explained. An in-depth analysis on the present state of Pharmacogenomics, progressive future trends, and comprehensive analysis based on type, application, players and regions are covered. The report thoroughly analyzes the competitors, SWOT analysis, industry chain structure and production process view.

Pharmacogenomics Market Leading Players (2019-2027:

Get A Free Sample Copy Here:

https://www.reportspedia.com/report/life-sciences/covid-19-outbreak-global-pharmacogenomics-industry-market-report-development-trends,-threats,-opportunities-and-competitive-landscape-in-2020/75523#request_sample

Market Segmentation:

Regional Analysis

Segmentation Market by Type

Market by Application

Download Free Sample Report Including Datailed Table Of Content

https://www.reportspedia.com/report/download#request_sample

1 Pharmacogenomics Introduction and Market Overview1.1 Objectives of the Study1.2 Overview of Pharmacogenomics1.3 Scope of The Study1.3.1 Key Market Segments1.3.2 Players Covered1.3.3 COVID-19s impact on the Pharmacogenomics industry1.4 Methodology of The Study1.5 Research Data Source

2 Executive Summary2.1 Market Overview2.1.1 Global Pharmacogenomics Market Size, 2015 20202.1.2 Global Pharmacogenomics Market Size by Type, 2015 20202.1.3 Global Pharmacogenomics Market Size by Application, 2015 20202.1.4 Global Pharmacogenomics Market Size by Region, 2015 2027br />2.2 Business Environment Analysis2.2.1 Global COVID-19 Status and Economic Overview2.2.2 Influence of COVID-19 Outbreak on Pharmacogenomics Industry Development

3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Pharmacogenomics Analysis3.2 Major Players of Pharmacogenomics3.3 Pharmacogenomics Manufacturing Cost Structure Analysis3.3.1 Production Process Analysis3.3.2 Manufacturing Cost Structure of Pharmacogenomics3.3.3 Labor Cost of Pharmacogenomics3.4 Market Distributors of Pharmacogenomics3.5 Major Downstream Buyers of Pharmacogenomics Analysis3.6 The Impact of Covid-19 From the Perspective of Industry Chain3.7 Regional Import and Export Controls Will Exist for a Long Time

Inquire Before Buying Or Ask For Custom Requirement:

https://www.reportspedia.com/report/life-sciences/covid-19-outbreak-global-pharmacogenomics-industry-market-report-development-trends,-threats,-opportunities-and-competitive-landscape-in-2020/75523#inquiry_before_buying

4 Global Pharmacogenomics Market, by Type4.1 Global Pharmacogenomics Value and Market Share by Type (2015-2020)4.2 Global Pharmacogenomics Production and Market Share by Type (2015-2020)4.3 Global Pharmacogenomics Value and Growth Rate by Type (2015-2020)

5 Pharmacogenomics Market, by Application5.1 Downstream Market Overview5.2 Global Pharmacogenomics Consumption and Market Share by Application (2015-2020)5.3 Global Pharmacogenomics Consumption and Growth Rate by Application (2015-2020)

Pharmacogenomics Report Will Answer Below Queries:

To know More Details About Pharmacogenomics Market research Report @:

https://www.reportspedia.com/report/life-sciences/covid-19-outbreak-global-pharmacogenomics-industry-market-report-development-trends,-threats,-opportunities-and-competitive-landscape-in-2020/75523#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]lmarketers.biz

Here is the original post:
Global Pharmacogenomics Market 2020 Outlook, Current and Future Industry Landscape Analysis 2027. - The Think Curiouser

GREENVILLE,S.C., Nov. 10, 2020 /PRNewswire/ --Precision Genetics, a leader in the molecular laboratory and technology industries, announces today the launch of a new diagnostic test that simultaneously detects SARS-CoV-2 and Influenza A/B strains in upper respiratory tract specimens. The test is available to health systems, providers, employers, and academic institutions alike.

Precision Genetics' capabilities are essential for accurately detecting patients with COVID-19 and/or the flu. "By utilizing our high-complexity laboratory and testing methods, we can quickly and accurately distinguish between these viral infections," said Nate Wilbourne, founder and CEO of Precision Genetics. "Our goal as a molecular laboratory is to ensure the highest levels of quality and efficiency to our clinical partners."

The addition of this combination test comes just in time for the flu season. "Most current testing looks only for COVID-19. As influenza infection rates rise, testing individuals only for Covid-19 is insufficient to distinguish between various viral illnesses of the upper respiratory tract," said John Wrangle, M.D,Chief Medical Officer of Precision Genetics. "Knowing which virus a patient is infected with may help treating physicians, health professionals and health departments decide on the best course of treatment, surveillance and contact tracing."

About Precision Genetics

Precision Genetics is a high-complex molecular laboratory and technology company performing COVID-19 testing, COVID-19/Flu combination testing and pharmacogenomics testing for employer safety and wellness, pre-surgical risk analysis and mental health.

For more information on how your organization can benefit from our quick and reliable testing capabilities, please visit us at https://precisiongenetics.com, send inquiries to [emailprotected], or call our team at (877) 843-6544 (ext 4).

SOURCE Precision Genetics

Home Page V2

Read the original post:
Precision Genetics Launches Combination Test to Detect COVID-19 and the Flu - PRNewswire